ZYNERBA PHARMACEUTICALS, INC. Deferred Revenue
ZYNERBA PHARMACEUTICALS, INC. had Deferred Revenue of $171.97 thousand as of 2017-12-31, per its 10-K filed 2018-03-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2018-03-12
- 2017-12-31: Deferred Revenue, Current $171.97K.
- 2017-09-30: Deferred Revenue, Current $833.98K.
- 2017-06-30: Deferred Revenue, Current $833.98K.
- 2017-03-31: Deferred Revenue, Current $833.98K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2017-12-31 | $171.97K 10-K · filed 2018-03-12 |
| 2017-09-30 | $833.98K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $833.98K 10-Q · filed 2017-08-01 |
| 2017-03-31 | $833.98K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $833.98K 10-K · filed 2018-03-12 |
| 2016-09-30 | $370.57K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $833.98K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $833.97K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $841.23K 10-K · filed 2017-03-27 |
| 2015-09-30 | $890.50K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $1.09M 10-Q · filed 2015-08-27 |
| 2014-12-31 | $1.12M 10-K · filed 2016-03-14 |